Parkinson’s disease and skin cancer risk: a nationwide population-based cohort study in Korea

H. J. Ryu; J. H. Park; M. Choi; J. H. Jung; K. Han; D. Y. Kwon; D. H. Kim; Y. G. Park

doi:10.1111/jdv.16462

Parkinson’s disease and skin cancer risk: a nationwide population-based cohort study in Korea

H. J. Ryu, J. H. Park, M. Choi, J. H. Jung, K. Han, D. Y. Kwon, D. H. Kim, Y. G. Park

Research output: Contribution to journal › Article › peer-review

16 Citations (Scopus)

Abstract

Background: Previous studies have reported that patients with Parkinson’s disease (PD) have a significantly lower risk of cancer. Studies reporting prevalence of skin cancers in Parkinson’s disease mostly involve Caucasians. Objective: A nationwide population-based study was conducted to determine the risk of skin cancer in patients diagnosed with PD in Korea. Methods: Data obtained from National Health Insurance Claims records were used to retrieve information about 70 780 patients with newly diagnosed PD between January 2010 and December 2015. The control group included 353 900 sex- and age-matched patients without PD. In this nationwide population-based cohort study, we investigated the association between PD and skin cancer. Results: The overall hazard ratio (HR) of skin cancers in patients with PD was 1.169 (95% CI, 1.005–1.359) compared with non-PD group. Among patients with PD, males aged above 65 had a 2.8-fold increase in the risk for melanoma development than the non-PD group (HR, 2.825; 95% CI, 1.395–5.721). In addition, female PD patients aged above 65 years showed a 1.3-fold increase in non-melanoma skin cancer risk than the non-PD group (HR, 1.305; 95% 1.073–1.589). Conclusion: Compared with the general population, Korean patients diagnosed with PD had a greater risk of skin cancer. Especially, male patients aged 65 years and above, and diagnosed with PD had a significant risk of melanoma development compared with control.

Original language	English
Pages (from-to)	2775-2780
Number of pages	6
Journal	Journal of the European Academy of Dermatology and Venereology
Volume	34
Issue number	12
DOIs	https://doi.org/10.1111/jdv.16462
Publication status	Published - 2020 Dec
Externally published	Yes

Bibliographical note

Funding Information:
Funding sources: This study was supported by Korea University Ansan Hospital Grant. The funding body had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. Other authors have not received any funding from any institution, including personal relationships, interests, grants, employment, affiliations, patents, inventions, honoraria, consultancies, royalties, stock options/ownership or expert testimony for the last 12 months.

Publisher Copyright:
© 2020 European Academy of Dermatology and Venereology

ASJC Scopus subject areas

Dermatology
Infectious Diseases

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/jdv.16462

Cite this

@article{7b15011d17a347e9895f63ec0715c876,

title = "Parkinson{\textquoteright}s disease and skin cancer risk: a nationwide population-based cohort study in Korea",

abstract = "Background: Previous studies have reported that patients with Parkinson{\textquoteright}s disease (PD) have a significantly lower risk of cancer. Studies reporting prevalence of skin cancers in Parkinson{\textquoteright}s disease mostly involve Caucasians. Objective: A nationwide population-based study was conducted to determine the risk of skin cancer in patients diagnosed with PD in Korea. Methods: Data obtained from National Health Insurance Claims records were used to retrieve information about 70 780 patients with newly diagnosed PD between January 2010 and December 2015. The control group included 353 900 sex- and age-matched patients without PD. In this nationwide population-based cohort study, we investigated the association between PD and skin cancer. Results: The overall hazard ratio (HR) of skin cancers in patients with PD was 1.169 (95% CI, 1.005–1.359) compared with non-PD group. Among patients with PD, males aged above 65 had a 2.8-fold increase in the risk for melanoma development than the non-PD group (HR, 2.825; 95% CI, 1.395–5.721). In addition, female PD patients aged above 65 years showed a 1.3-fold increase in non-melanoma skin cancer risk than the non-PD group (HR, 1.305; 95% 1.073–1.589). Conclusion: Compared with the general population, Korean patients diagnosed with PD had a greater risk of skin cancer. Especially, male patients aged 65 years and above, and diagnosed with PD had a significant risk of melanoma development compared with control.",

author = "Ryu, {H. J.} and Park, {J. H.} and M. Choi and Jung, {J. H.} and K. Han and Kwon, {D. Y.} and Kim, {D. H.} and Park, {Y. G.}",

note = "Funding Information: Funding sources: This study was supported by Korea University Ansan Hospital Grant. The funding body had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. Other authors have not received any funding from any institution, including personal relationships, interests, grants, employment, affiliations, patents, inventions, honoraria, consultancies, royalties, stock options/ownership or expert testimony for the last 12 months. Publisher Copyright: {\textcopyright} 2020 European Academy of Dermatology and Venereology",

year = "2020",

month = dec,

doi = "10.1111/jdv.16462",

language = "English",

volume = "34",

pages = "2775--2780",

journal = "Journal of the European Academy of Dermatology and Venereology",

issn = "0926-9959",

publisher = "Wiley-Blackwell",

number = "12",

}

TY - JOUR

T1 - Parkinson’s disease and skin cancer risk

T2 - a nationwide population-based cohort study in Korea

AU - Ryu, H. J.

AU - Park, J. H.

AU - Choi, M.

AU - Jung, J. H.

AU - Han, K.

AU - Kwon, D. Y.

AU - Kim, D. H.

AU - Park, Y. G.

N1 - Funding Information: Funding sources: This study was supported by Korea University Ansan Hospital Grant. The funding body had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. Other authors have not received any funding from any institution, including personal relationships, interests, grants, employment, affiliations, patents, inventions, honoraria, consultancies, royalties, stock options/ownership or expert testimony for the last 12 months. Publisher Copyright: © 2020 European Academy of Dermatology and Venereology

PY - 2020/12

Y1 - 2020/12

N2 - Background: Previous studies have reported that patients with Parkinson’s disease (PD) have a significantly lower risk of cancer. Studies reporting prevalence of skin cancers in Parkinson’s disease mostly involve Caucasians. Objective: A nationwide population-based study was conducted to determine the risk of skin cancer in patients diagnosed with PD in Korea. Methods: Data obtained from National Health Insurance Claims records were used to retrieve information about 70 780 patients with newly diagnosed PD between January 2010 and December 2015. The control group included 353 900 sex- and age-matched patients without PD. In this nationwide population-based cohort study, we investigated the association between PD and skin cancer. Results: The overall hazard ratio (HR) of skin cancers in patients with PD was 1.169 (95% CI, 1.005–1.359) compared with non-PD group. Among patients with PD, males aged above 65 had a 2.8-fold increase in the risk for melanoma development than the non-PD group (HR, 2.825; 95% CI, 1.395–5.721). In addition, female PD patients aged above 65 years showed a 1.3-fold increase in non-melanoma skin cancer risk than the non-PD group (HR, 1.305; 95% 1.073–1.589). Conclusion: Compared with the general population, Korean patients diagnosed with PD had a greater risk of skin cancer. Especially, male patients aged 65 years and above, and diagnosed with PD had a significant risk of melanoma development compared with control.

AB - Background: Previous studies have reported that patients with Parkinson’s disease (PD) have a significantly lower risk of cancer. Studies reporting prevalence of skin cancers in Parkinson’s disease mostly involve Caucasians. Objective: A nationwide population-based study was conducted to determine the risk of skin cancer in patients diagnosed with PD in Korea. Methods: Data obtained from National Health Insurance Claims records were used to retrieve information about 70 780 patients with newly diagnosed PD between January 2010 and December 2015. The control group included 353 900 sex- and age-matched patients without PD. In this nationwide population-based cohort study, we investigated the association between PD and skin cancer. Results: The overall hazard ratio (HR) of skin cancers in patients with PD was 1.169 (95% CI, 1.005–1.359) compared with non-PD group. Among patients with PD, males aged above 65 had a 2.8-fold increase in the risk for melanoma development than the non-PD group (HR, 2.825; 95% CI, 1.395–5.721). In addition, female PD patients aged above 65 years showed a 1.3-fold increase in non-melanoma skin cancer risk than the non-PD group (HR, 1.305; 95% 1.073–1.589). Conclusion: Compared with the general population, Korean patients diagnosed with PD had a greater risk of skin cancer. Especially, male patients aged 65 years and above, and diagnosed with PD had a significant risk of melanoma development compared with control.

UR - http://www.scopus.com/inward/record.url?scp=85084511182&partnerID=8YFLogxK

U2 - 10.1111/jdv.16462

DO - 10.1111/jdv.16462

M3 - Article

C2 - 32289877

AN - SCOPUS:85084511182

SN - 0926-9959

VL - 34

SP - 2775

EP - 2780

JO - Journal of the European Academy of Dermatology and Venereology

JF - Journal of the European Academy of Dermatology and Venereology

IS - 12

ER -

Parkinson’s disease and skin cancer risk: a nationwide population-based cohort study in Korea

Abstract

Bibliographical note

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this